Microlife WatchBP Office Central (Twin200 CBP)
The technology used in the Microlife WatchBP Office Central (Twin200 CBP), to measure blood pressure, has passed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication.
|Medaval||★ Recommendation||Recent clinical validation; older protocol|
|ESH (Europe)||Professional use||Published evidence|
|Stride BP||Professional use for adults and children (Preferred)||Published evidence|
|AMA VDL Criteria||Satisfies stated criteria||510(k) K171937 plus SP10:2002 validation|
Cheng HM, Sung SH, Shih YT, Chuang SY, Yu WC, Chen CH. Measurement accuracy of a stand-alone oscillometric central blood pressure monitor: a validation report for Microlife WatchBP Office Central. Am J Hypertens. 2013 Jan;26(1):42-50. doi: 10.1093/ajh/hps021. PMID: 23382326.
SP10:2002 - Fail General population (Note: IA validation cuff BP (n=255/85))
SP10:2002 - Pass Central BP (n=255/85) (Note: IA validation)